BioSpace News Archive

Leading researchers in emergency medicine will present nearly 500 studies during the Research Forum at ACEP18-Scientific Assembly, the annual meeting of the American College of Emergency Physicians (ACEP) at the San Diego Convention Center from October 1-3, 2018.

A new research article highlights the potential of future campaigns to reduce risk of serious injury in teens and other riders

The Alzheimer’s Research and Prevention Foundation (ARPF) announced today that its paper, “Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands, Khalsa, DS (2015),” published in The Journal of Alzheimer’s Disease (JAD) was ranked as one of the top 10 JAD-viewed articles in 2017, out of 500+ articles published each year.

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has made three senior appointments to its Analytical Services Division.

Calyxt, Inc. (NASDAQ:CLXT) and Cellectis S.A. (NASDAQ:CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018.

Presentation to Highlight UNITE technology application to oncology

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it has submitted a Special Protocol Assessment (SPA) request to the U.S. Food and Drug Administration (FDA).

Neovasc Inc. announced today that the Company has filed articles of amendment, effective today, to effect the previously announced share consolidation of its issued and outstanding common shares

PureCircle filed a complaint in the U.S. District Court for the Central District of California against Sweegen, Inc. PureCircle claims that Sweegen’s Bestevia® Reb-M is infringing PureCircle’s patent -- U.S. Patent No. 9,243,273, A Method for Making Rebaudioside M (Reb-M).

BioClin Therapeutics, Inc. today announced the appointment of Scott Myers as Chief Executive Officer, and Julie Eastland as Chief Financial Officer and Chief Business Officer. Mr. Myers will also continue in his role as company Chairman.